BridgeMD
New treatment option for Heart Failure
Official title Timely Interventions to Enable and Reach Patients With Heart Failure, and Their Caregivers With Palliative Care
ClinicalTrials.gov ID: NCT06244953
What this study is testing
- What it's testing
- There is evidence for the effectiveness and feasibility of the individual components of TIER-HF-PC, however there is a need to test how these individual components interact to allow the researchers to deliver TIER-HF-PC as a model of care in its totality. In the short term, this study will assess if TIER-HF-PC is beneficial for patients and caregivers.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 99
You may be able to join if
- Patients:
- 21 years or older and
- able to communicate in English/Chinese/Malay and
- be of stage C or D heart failure, as defined by American College of Cardiology/American Heart Association (ACC/AHA) classification system and
- have functional limitation of New York Heart Association (NYHA) functional status of at least 2 or more and
You likely can't join if
- Patients:
- have cognitive impairment (e.g., dementia)
- have severe, untreated, active mental illness (e.g., major depressive disorder)
- have ventricular assist device implant.
- have non-reversible hearing or visual loss or
- are active drug abuser or
See the full eligibility criteria
- Patients:
- 21 years or older and
- able to communicate in English/Chinese/Malay and
- be of stage C or D heart failure, as defined by American College of Cardiology/American Heart Association (ACC/AHA) classification system and
- have functional limitation of New York Heart Association (NYHA) functional status of at least 2 or more and
- be deemed by their cardiologist's clinical judgement to have an expected prognosis of at least 6 months survival, and
- have had a heart failure related hospitalization event (e.g. symptomatic decompensated heart failure) within 6 months prior to recruitment and
- have a phone that allows telecommunication.
- Caregivers must meet all the following to be eligible for the study :
- direct, unpaid, family caregiver of the patient;
- self-reported by the patient to be the main person to be either:
- responsible for up to 4 hours a day of caregiving tasks
- and/or decision maker/spokesperson with the medical team
- Caregiver may or may not live in the same residence as the patient.
- Caregivers must be 21 years and above.
- Able to communicate in English/Chinese/Malay.
- Patients:
- have cognitive impairment (e.g., dementia)
- have severe, untreated, active mental illness (e.g., major depressive disorder)
- have ventricular assist device implant.
- have non-reversible hearing or visual loss or
- are active drug abuser or
- already known to a palliative care service.
- Caregivers who meet any of the exclusion criteria at baseline will be ineligible for the study:
- have cognitive impairment (e.g., dementia) or
- have severe, untreated, active mental illness (e.g., major depressive disorder)
- have non-reversible hearing or visual loss.
- are active drug abuser or
- are a domestic helper for the patient
The study team makes the final eligibility decision.
Where it's taking place
- Singapore, Singapore
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Singapore, Singapore. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.